查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1403476

到 2030 年药品折扣卡市场预测：按类型、治疗类别、销售管道、最终用户和地区进行的全球分析

Drug Discount Card Market Forecasts to 2030 - Global Analysis By Type, By Therapeutic Category, By Sales Channel, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球药品折扣卡市场规模为 2,720 万美元，预计在预测期内将以 9.8% 的复合年增长率增长，并在 2030 年达到 5,230 万美元。

药品折扣卡是提供处方笺药折扣价格的计划。这些卡片由多种资讯来源提供，包括雇主、保险公司和患者援助计划。节省的费用可能是巨大的，特别是对于那些没有保险或自付额较高的人来说。

根据美国国立卫生研究院 2019 年发布的资料，只有 31% 的千禧世代了解处方笺折扣计画。

医疗费用上涨

医疗保健成本不断上升，增加了对负担得起的药物的需求。药品折扣计划和平台已成为为消费者提供处方药折扣价格的重要解决方案。这些计划弥合了药品成本急剧上升和患者经济困难之间的差距，确保更好地获得基本药物。对具有成本效益的医疗保健解决方案的需求不断增长，加上慢性病的流行，使药品折扣市场成为应对医疗保健行业经济挑战的关键参与者。

药品承保范围有限

儘管有药物折扣计划，但仍有大量药物可能不在保险范围内，使患者需要承担高昂的自付费用。这种限制可能会对需要持续药物治疗的慢性病患者产生不成比例的影响。此外，缺乏保险覆盖范围阻碍了药品折扣计划的有效性，并限制了其提高医疗保健负担能力的有效性。因此，患者在获得所需药物方面面临经济障碍，这可能会影响对治疗计划的遵守和整体健康结果。

与医疗保健提供者合作

医药企业、药品折扣平台与医疗机构结成策略伙伴关係，帮助患者以折扣价格取得药品。这些合作关係使医疗保健提供者能够提供具有成本效益的处方解决方案，促进患者用药医嘱遵从性和整体健康。此外，该合作伙伴关係还将有助于建立更精简的医疗保健生态系统，促进提供者和药品折扣平台之间更好的沟通和协调，并最终增加更多人获得基本药物的机会。提高负担能力和可得性。

资料安全问题

该行业越来越多地采用数位平台和电子健康记录来管理药品折扣和患者资讯，从而增加了网路威胁和资料外洩的风险。诈欺存取患者资料不仅使个人隐私面临风险，还使他们面临资讯盗窃和诈骗的风险。此外，资料受损可能会削弱折扣计划的有效性，并削弱消费者对医疗保健系统的信心。

COVID-19 的影响：

随着世界各地的医疗保健系统将重点转向大流行应对，药品折扣市场因 COVID-19 大流行而面临严重干扰。封锁、供应链中断、医疗机构就诊次数减少等都影响了市场。患者在以折扣价获得药品方面面临挑战，製药公司调整策略以应对不断变化的情况。儘管出现了一些短期挫折，但这场大流行凸显了负担得起的药品的重要性，并可能支持未来加强药品折扣计划的创新和政策。

零售药房连锁店预计将在预测期内成为最大的细分市场

零售药局连锁产业的市场规模预计在预测期内将会增加。这些连锁店利用其广泛的网路和购买力与药品製造商协商价格，并将节省的成本转嫁给消费者。随着消费者寻求负担得起的医疗保健，零售药局连锁店在以折扣价提供处方药和非处方药方面发挥重要作用。其广泛的影响力和具有竞争力的定价为塑造药品折扣市场形势做出了重大贡献，满足了多样化且注重成本的医疗保健消费者的需求。

线下产业预计在预测期间内复合年增长率最高

预计线下业务在预测期内将出现良好成长。这可能包括实体优惠券、药房的面对面互动或其他获得处方药折扣的非数位方式。儘管线上平台越来越普及，但线下管道仍然适合那些喜欢或无法存取数位资源的个人。这种结合了线下和线上策略的双重方法，确保了消费者在药品折扣市场寻求具有成本效益的选择的更广泛的覆盖范围和可及性。

占比最大的地区：

北美地区预计将占据最大的市场占有率。数位健康平台和处方笺折扣计划在该地区很普及，为消费者提供药品折扣。随着医疗保健成本的不断上升以及对负担得起的治疗方案的需求，北美的这些倡议旨在解决药物医嘱遵从性的财务障碍，并确保个人获得更好的健康结果。该地区的市场是由共同努力推动的，旨在让更多人更容易获得和负担得起医疗保健。

复合年增长率最高的地区：

在预测期内，由于医疗保健成本上升、处方笺折扣意识增强以及中国和印度等国家药品市场不断扩大等因素，亚太地区预计将快速成长。对平价药品的需求正在推动药品折扣计划的推出，使消费者和医疗保健提供者都受益。亚太地区不断变化的医疗保健环境和对具有成本效益的解决方案的追求正在促进亚太地区药品折扣市场的蓬勃发展，这为製药公司和医疗保健服务供应商面临的可及性和可负担性挑战提供了解决的机会。

免费客製化服务

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球药品折扣卡市场：按类型

  • 药局社会福利经理 (PBM)
  • 零售药局连锁店
  • 直接面向消费者的平台
  • 非营利机构
  • 其他类型

第六章全球药品折扣卡市场：依治疗类别

  • 心血管药物
  • 糖尿病药物
  • 止痛药
  • 心理健康医学
  • 抗癌剂
  • 其他治疗类别

第七章全球药品折扣卡市场：依销售管道

  • 在线的
  • 离线

第八章全球药品折扣卡市场：依最终用户分类

  • 学名药
  • 品牌药品
  • 特殊药品
  • 其他最终用户

第九章全球药品折扣卡市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第10章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司简介

  • GoodRx
  • SingleCare
  • WellCard Savings
  • RxSaver
  • Optum Perks
  • Kroger Prescription Savings Club
  • ScriptSave
  • Walmart Rx Savings Program
  • Prescription Hope
  • FamilyWize
  • NeedyMeds
  • Humana
Product Code: SMRC24701

According to Stratistics MRC, the Global Drug Discount Card Market is accounted for $27.2 million in 2023 and is expected to reach $52.3 million by 2030 growing at a CAGR of 9.8% during the forecast period. A Drug Discount Card is a program that offers reduced prices on prescription medications. These cards are offered by various sources like employers, insurance companies, and patient assistance programs. They can help individuals save significantly, especially those without insurance or high deductibles.

According to data published by National Institute of Health in 2019, only 31% of the millennial population was aware of prescription discount programs.

Market Dynamics:

Driver:

Rising healthcare costs

Healthcare expenses escalate there is an increasing need for affordable medication. Drug discount programs and platforms emerge as a crucial solution, offering consumers discounted prices on prescription medications. These programs bridge the gap between rising drug costs and the financial constraints of patients, ensuring better access to essential medications. The rising demand for cost-effective healthcare solutions, coupled with the prevalence of chronic diseases, positions the Drug Discount Market as a vital player in addressing the affordability challenges within the healthcare sector.

Restraint:

Limited drug coverage

Despite the presence of drug discount programs, a substantial number of medications may not be covered, leaving patients with high out-of-pocket expenses. This limitation can disproportionately affect individuals with chronic conditions who require ongoing medication. Additionally, the lack of coverage hampers the effectiveness of drug discount initiatives, limiting their impact on improving healthcare affordability. As a result, patients may face financial barriers to accessing essential medications, compromising their adherence to treatment plans and overall health outcomes.

Opportunity:

Partnering with healthcare providers

By forming strategic partnerships with medical institutions, pharmaceutical companies and drug discount platforms can enhance accessibility to discounted medications for patients. Such collaborations enable healthcare providers to offer cost-effective prescription solutions, promoting patient adherence and overall wellness. Additionally, partnerships contribute to a more streamlined healthcare ecosystem, fostering better communication and coordination between providers and drug discount platforms, ultimately improving the affordability and availability of essential medications for a broader population.

Threat:

Data security concerns

The industry increasingly adopts digital platforms and electronic health records for managing drug discounts and patient information, the risk of cyber threats and data breaches escalates. Unauthorized access to patient data not only jeopardizes individuals' privacy but also exposes them to potential identity theft and fraud. Moreover, compromised data integrity can undermine the efficacy of discount programs and erode consumer trust in the healthcare system.

COVID-19 Impact:

The Drug Discount Market faced significant disruptions due to the COVID-19 pandemic as healthcare systems worldwide shifted focus to pandemic response. Lockdowns, supply chain disruptions, and reduced healthcare facility visits impacted the market. Patients faced challenges in accessing discounted medications, and pharmaceutical companies adjusted their strategies to navigate the evolving landscape. Despite short-term setbacks, the pandemic underscored the importance of affordable medications, potentially driving future innovations and policies to enhance drug discount programs, making healthcare more accessible and resilient in the face of global uncertainties.

The retail pharmacy chains segment is expected to be the largest during the forecast period

Over the projection period, it is predicted that the retail pharmacy chains segment will experience a larger market size. These chains leverage their extensive network and purchasing power to negotiate lower prices from drug manufacturers, passing on the cost savings to consumers. As consumers seek affordable healthcare solutions, retail pharmacy chains play a crucial role in providing discounted prescription medications and over-the-counter drugs. Their widespread presence and competitive pricing contribute significantly to shaping the landscape of the Drug Discount Market, catering to the needs of diverse and cost-conscious healthcare consumers.

The offline segment is expected to have the highest CAGR during the forecast period

During the forecast period, it is expected that the offline segment will experience lucrative growth. This may involve physical coupons, in-person interactions at pharmacies, or other non-digital means of obtaining discounts on prescription medications. Despite the increasing prevalence of online platforms, offline channels remain relevant for individuals who prefer or have limited access to digital resources. This dual approach, combining both offline and online strategies, ensures a broader reach and accessibility for consumers seeking cost-effective options in the Drug Discount market.

Region with largest share:

The North America region is expected to witness largest market share. The region witnesses the proliferation of digital health platforms and prescription discount programs, offering consumers discounted prices on pharmaceuticals. With rising healthcare expenses and the need for affordable treatment options, these initiatives in North America aim to address financial barriers to medication adherence, ensuring better health outcomes for individuals. The market is driven by a concerted effort to make healthcare more accessible and affordable for a broader population in the region.

Region with highest CAGR:

During the forecast period, a rapid growth rate is anticipated in the Asia-Pacific region due to factors such as rising healthcare expenditures, increasing awareness of prescription discounts, and expanding pharmaceutical markets in countries like China and India. The demand for affordable medications has fuelled the adoption of drug discount programs, benefiting both consumers and healthcare providers. The region's evolving healthcare landscape and the pursuit of cost-effective solutions contribute to the thriving Drug Discount Market in Asia Pacific, offering opportunities for pharmaceutical companies and healthcare service providers to address accessibility and affordability challenges.

Key players in the market:

Some of the key players in Drug Discount Card market include GoodRx, SingleCare, WellCard Savings, RxSaver, Optum Perks, Kroger Prescription Savings Club, ScriptSave, Walmart Rx Savings Program, Prescription Hope, FamilyWize, NeedyMeds and Humana.

Key Developments:

In September 2023, GoodRx, a U.S.-based healthcare company that operates a telemedicine platform and free-to-use website and mobile app that track prescription drug prices, announced a partnership with MedImpact, an independent, trend-focused pharmacy benefit manager (PBM), to integrate its drug coupons at the point of sale.

In July 2023, CVS Caremark, a CVS Health company and GoodRx, a leading resource for healthcare savings and information, announced the launch of Caremark Cost SaverTM to help lower pharmacy out-of-pocket drug costs for CVS Caremark clients' members.

In January 2023, Amazon Pharmacy, the company offering free, two-day home delivery of prescriptions to Amazon Prime subscribers introduced RxPass a US$5 prescription subscription new Prime membership benefit from Amazon Pharmacy that provides patients with affordable access to generic medications that treat more than 80 common health conditions for just US$5 a month.

Types Covered:

  • Pharmacy Benefit Managers (PBMs)
  • Retail Pharmacy Chains
  • Direct-to-Consumer Platforms
  • Non-Profit Organizations
  • Other Types

Therapeutic Categories Covered:

  • Cardiovascular drugs
  • Diabetes drugs
  • Pain medications
  • Mental health medications
  • Cancer drugs
  • Other Therapeutic Categories

Sales Channels Covered:

  • Online
  • Offline

End Users Covered:

  • Generic Drugs
  • Branded Drugs
  • Specialty Medications
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Drug Discount Card Market, By Type

  • 5.1 Introduction
  • 5.2 Pharmacy Benefit Managers (PBMs)
  • 5.3 Retail Pharmacy Chains
  • 5.4 Direct-to-Consumer Platforms
  • 5.5 Non-Profit Organizations
  • 5.6 Other Types

6 Global Drug Discount Card Market, By Therapeutic Category

  • 6.1 Introduction
  • 6.2 Cardiovascular Drugs
  • 6.3 Diabetes Drugs
  • 6.4 Pain Medications
  • 6.5 Mental Health Medications
  • 6.6 Cancer Drugs
  • 6.7 Other Therapeutic Categories

7 Global Drug Discount Card Market, By Sales Channel

  • 7.1 Introduction
  • 7.2 Online
  • 7.3 Offline

8 Global Drug Discount Card Market, By End User

  • 8.1 Introduction
  • 8.2 Generic Drugs
  • 8.3 Branded Drugs
  • 8.4 Specialty Medications
  • 8.5 Other End Users

9 Global Drug Discount Card Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 GoodRx
  • 11.2 SingleCare
  • 11.3 WellCard Savings
  • 11.4 RxSaver
  • 11.5 Optum Perks
  • 11.6 Kroger Prescription Savings Club
  • 11.7 ScriptSave
  • 11.8 Walmart Rx Savings Program
  • 11.9 Prescription Hope
  • 11.10 FamilyWize
  • 11.11 NeedyMeds
  • 11.12 Humana

List of Tables

  • Table 1 Global Drug Discount Card Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Drug Discount Card Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Drug Discount Card Market Outlook, By Pharmacy Benefit Managers (PBMs) (2021-2030) ($MN)
  • Table 4 Global Drug Discount Card Market Outlook, By Retail Pharmacy Chains (2021-2030) ($MN)
  • Table 5 Global Drug Discount Card Market Outlook, By Direct-to-Consumer Platforms (2021-2030) ($MN)
  • Table 6 Global Drug Discount Card Market Outlook, By Non-Profit Organizations (2021-2030) ($MN)
  • Table 7 Global Drug Discount Card Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 8 Global Drug Discount Card Market Outlook, By Therapeutic Category (2021-2030) ($MN)
  • Table 9 Global Drug Discount Card Market Outlook, By Cardiovascular Drugs (2021-2030) ($MN)
  • Table 10 Global Drug Discount Card Market Outlook, By Diabetes Drugs (2021-2030) ($MN)
  • Table 11 Global Drug Discount Card Market Outlook, By Pain Medications (2021-2030) ($MN)
  • Table 12 Global Drug Discount Card Market Outlook, By Mental Health Medications (2021-2030) ($MN)
  • Table 13 Global Drug Discount Card Market Outlook, By Cancer Drugs (2021-2030) ($MN)
  • Table 14 Global Drug Discount Card Market Outlook, By Other Therapeutic Categories (2021-2030) ($MN)
  • Table 15 Global Drug Discount Card Market Outlook, By Sales Channel (2021-2030) ($MN)
  • Table 16 Global Drug Discount Card Market Outlook, By Online (2021-2030) ($MN)
  • Table 17 Global Drug Discount Card Market Outlook, By Offline (2021-2030) ($MN)
  • Table 18 Global Drug Discount Card Market Outlook, By End User (2021-2030) ($MN)
  • Table 19 Global Drug Discount Card Market Outlook, By Generic Drugs (2021-2030) ($MN)
  • Table 20 Global Drug Discount Card Market Outlook, By Branded Drugs (2021-2030) ($MN)
  • Table 21 Global Drug Discount Card Market Outlook, By Specialty Medications (2021-2030) ($MN)
  • Table 22 North America Drug Discount Card Market Outlook, By Country (2021-2030) ($MN)
  • Table 23 North America Drug Discount Card Market Outlook, By Type (2021-2030) ($MN)
  • Table 24 North America Drug Discount Card Market Outlook, By Pharmacy Benefit Managers (PBMs) (2021-2030) ($MN)
  • Table 25 North America Drug Discount Card Market Outlook, By Retail Pharmacy Chains (2021-2030) ($MN)
  • Table 26 North America Drug Discount Card Market Outlook, By Direct-to-Consumer Platforms (2021-2030) ($MN)
  • Table 27 North America Drug Discount Card Market Outlook, By Non-Profit Organizations (2021-2030) ($MN)
  • Table 28 North America Drug Discount Card Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 29 North America Drug Discount Card Market Outlook, By Therapeutic Category (2021-2030) ($MN)
  • Table 30 North America Drug Discount Card Market Outlook, By Cardiovascular Drugs (2021-2030) ($MN)
  • Table 31 North America Drug Discount Card Market Outlook, By Diabetes Drugs (2021-2030) ($MN)
  • Table 32 North America Drug Discount Card Market Outlook, By Pain Medications (2021-2030) ($MN)
  • Table 33 North America Drug Discount Card Market Outlook, By Mental Health Medications (2021-2030) ($MN)
  • Table 34 North America Drug Discount Card Market Outlook, By Cancer Drugs (2021-2030) ($MN)
  • Table 35 North America Drug Discount Card Market Outlook, By Other Therapeutic Categories (2021-2030) ($MN)
  • Table 36 North America Drug Discount Card Market Outlook, By Sales Channel (2021-2030) ($MN)
  • Table 37 North America Drug Discount Card Market Outlook, By Online (2021-2030) ($MN)
  • Table 38 North America Drug Discount Card Market Outlook, By Offline (2021-2030) ($MN)
  • Table 39 North America Drug Discount Card Market Outlook, By End User (2021-2030) ($MN)
  • Table 40 North America Drug Discount Card Market Outlook, By Generic Drugs (2021-2030) ($MN)
  • Table 41 North America Drug Discount Card Market Outlook, By Branded Drugs (2021-2030) ($MN)
  • Table 42 North America Drug Discount Card Market Outlook, By Specialty Medications (2021-2030) ($MN)
  • Table 43 North America Drug Discount Card Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 44 Europe Drug Discount Card Market Outlook, By Country (2021-2030) ($MN)
  • Table 45 Europe Drug Discount Card Market Outlook, By Type (2021-2030) ($MN)
  • Table 46 Europe Drug Discount Card Market Outlook, By Pharmacy Benefit Managers (PBMs) (2021-2030) ($MN)
  • Table 47 Europe Drug Discount Card Market Outlook, By Retail Pharmacy Chains (2021-2030) ($MN)
  • Table 48 Europe Drug Discount Card Market Outlook, By Direct-to-Consumer Platforms (2021-2030) ($MN)
  • Table 49 Europe Drug Discount Card Market Outlook, By Non-Profit Organizations (2021-2030) ($MN)
  • Table 50 Europe Drug Discount Card Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 51 Europe Drug Discount Card Market Outlook, By Therapeutic Category (2021-2030) ($MN)
  • Table 52 Europe Drug Discount Card Market Outlook, By Cardiovascular Drugs (2021-2030) ($MN)
  • Table 53 Europe Drug Discount Card Market Outlook, By Diabetes Drugs (2021-2030) ($MN)
  • Table 54 Europe Drug Discount Card Market Outlook, By Pain Medications (2021-2030) ($MN)
  • Table 55 Europe Drug Discount Card Market Outlook, By Mental Health Medications (2021-2030) ($MN)
  • Table 56 Europe Drug Discount Card Market Outlook, By Cancer Drugs (2021-2030) ($MN)
  • Table 57 Europe Drug Discount Card Market Outlook, By Other Therapeutic Categories (2021-2030) ($MN)
  • Table 58 Europe Drug Discount Card Market Outlook, By Sales Channel (2021-2030) ($MN)
  • Table 59 Europe Drug Discount Card Market Outlook, By Online (2021-2030) ($MN)
  • Table 60 Europe Drug Discount Card Market Outlook, By Offline (2021-2030) ($MN)
  • Table 61 Europe Drug Discount Card Market Outlook, By End User (2021-2030) ($MN)
  • Table 62 Europe Drug Discount Card Market Outlook, By Generic Drugs (2021-2030) ($MN)
  • Table 63 Europe Drug Discount Card Market Outlook, By Branded Drugs (2021-2030) ($MN)
  • Table 64 Europe Drug Discount Card Market Outlook, By Specialty Medications (2021-2030) ($MN)
  • Table 65 Europe Drug Discount Card Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 66 Asia Pacific Drug Discount Card Market Outlook, By Country (2021-2030) ($MN)
  • Table 67 Asia Pacific Drug Discount Card Market Outlook, By Type (2021-2030) ($MN)
  • Table 68 Asia Pacific Drug Discount Card Market Outlook, By Pharmacy Benefit Managers (PBMs) (2021-2030) ($MN)
  • Table 69 Asia Pacific Drug Discount Card Market Outlook, By Retail Pharmacy Chains (2021-2030) ($MN)
  • Table 70 Asia Pacific Drug Discount Card Market Outlook, By Direct-to-Consumer Platforms (2021-2030) ($MN)
  • Table 71 Asia Pacific Drug Discount Card Market Outlook, By Non-Profit Organizations (2021-2030) ($MN)
  • Table 72 Asia Pacific Drug Discount Card Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 73 Asia Pacific Drug Discount Card Market Outlook, By Therapeutic Category (2021-2030) ($MN)
  • Table 74 Asia Pacific Drug Discount Card Market Outlook, By Cardiovascular Drugs (2021-2030) ($MN)
  • Table 75 Asia Pacific Drug Discount Card Market Outlook, By Diabetes Drugs (2021-2030) ($MN)
  • Table 76 Asia Pacific Drug Discount Card Market Outlook, By Pain Medications (2021-2030) ($MN)
  • Table 77 Asia Pacific Drug Discount Card Market Outlook, By Mental Health Medications (2021-2030) ($MN)
  • Table 78 Asia Pacific Drug Discount Card Market Outlook, By Cancer Drugs (2021-2030) ($MN)
  • Table 79 Asia Pacific Drug Discount Card Market Outlook, By Other Therapeutic Categories (2021-2030) ($MN)
  • Table 80 Asia Pacific Drug Discount Card Market Outlook, By Sales Channel (2021-2030) ($MN)
  • Table 81 Asia Pacific Drug Discount Card Market Outlook, By Online (2021-2030) ($MN)
  • Table 82 Asia Pacific Drug Discount Card Market Outlook, By Offline (2021-2030) ($MN)
  • Table 83 Asia Pacific Drug Discount Card Market Outlook, By End User (2021-2030) ($MN)
  • Table 84 Asia Pacific Drug Discount Card Market Outlook, By Generic Drugs (2021-2030) ($MN)
  • Table 85 Asia Pacific Drug Discount Card Market Outlook, By Branded Drugs (2021-2030) ($MN)
  • Table 86 Asia Pacific Drug Discount Card Market Outlook, By Specialty Medications (2021-2030) ($MN)
  • Table 87 Asia Pacific Drug Discount Card Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 88 South America Drug Discount Card Market Outlook, By Country (2021-2030) ($MN)
  • Table 89 South America Drug Discount Card Market Outlook, By Type (2021-2030) ($MN)
  • Table 90 South America Drug Discount Card Market Outlook, By Pharmacy Benefit Managers (PBMs) (2021-2030) ($MN)
  • Table 91 South America Drug Discount Card Market Outlook, By Retail Pharmacy Chains (2021-2030) ($MN)
  • Table 92 South America Drug Discount Card Market Outlook, By Direct-to-Consumer Platforms (2021-2030) ($MN)
  • Table 93 South America Drug Discount Card Market Outlook, By Non-Profit Organizations (2021-2030) ($MN)
  • Table 94 South America Drug Discount Card Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 95 South America Drug Discount Card Market Outlook, By Therapeutic Category (2021-2030) ($MN)
  • Table 96 South America Drug Discount Card Market Outlook, By Cardiovascular Drugs (2021-2030) ($MN)
  • Table 97 South America Drug Discount Card Market Outlook, By Diabetes Drugs (2021-2030) ($MN)
  • Table 98 South America Drug Discount Card Market Outlook, By Pain Medications (2021-2030) ($MN)
  • Table 99 South America Drug Discount Card Market Outlook, By Mental Health Medications (2021-2030) ($MN)
  • Table 100 South America Drug Discount Card Market Outlook, By Cancer Drugs (2021-2030) ($MN)
  • Table 101 South America Drug Discount Card Market Outlook, By Other Therapeutic Categories (2021-2030) ($MN)
  • Table 102 South America Drug Discount Card Market Outlook, By Sales Channel (2021-2030) ($MN)
  • Table 103 South America Drug Discount Card Market Outlook, By Online (2021-2030) ($MN)
  • Table 104 South America Drug Discount Card Market Outlook, By Offline (2021-2030) ($MN)
  • Table 105 South America Drug Discount Card Market Outlook, By End User (2021-2030) ($MN)
  • Table 106 South America Drug Discount Card Market Outlook, By Generic Drugs (2021-2030) ($MN)
  • Table 107 South America Drug Discount Card Market Outlook, By Branded Drugs (2021-2030) ($MN)
  • Table 108 South America Drug Discount Card Market Outlook, By Specialty Medications (2021-2030) ($MN)
  • Table 109 South America Drug Discount Card Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 110 Middle East & Africa Drug Discount Card Market Outlook, By Country (2021-2030) ($MN)
  • Table 111 Middle East & Africa Drug Discount Card Market Outlook, By Type (2021-2030) ($MN)
  • Table 112 Middle East & Africa Drug Discount Card Market Outlook, By Pharmacy Benefit Managers (PBMs) (2021-2030) ($MN)
  • Table 113 Middle East & Africa Drug Discount Card Market Outlook, By Retail Pharmacy Chains (2021-2030) ($MN)
  • Table 114 Middle East & Africa Drug Discount Card Market Outlook, By Direct-to-Consumer Platforms (2021-2030) ($MN)
  • Table 115 Middle East & Africa Drug Discount Card Market Outlook, By Non-Profit Organizations (2021-2030) ($MN)
  • Table 116 Middle East & Africa Drug Discount Card Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 117 Middle East & Africa Drug Discount Card Market Outlook, By Therapeutic Category (2021-2030) ($MN)
  • Table 118 Middle East & Africa Drug Discount Card Market Outlook, By Cardiovascular Drugs (2021-2030) ($MN)
  • Table 119 Middle East & Africa Drug Discount Card Market Outlook, By Diabetes Drugs (2021-2030) ($MN)
  • Table 120 Middle East & Africa Drug Discount Card Market Outlook, By Pain Medications (2021-2030) ($MN)
  • Table 121 Middle East & Africa Drug Discount Card Market Outlook, By Mental Health Medications (2021-2030) ($MN)
  • Table 122 Middle East & Africa Drug Discount Card Market Outlook, By Cancer Drugs (2021-2030) ($MN)
  • Table 123 Middle East & Africa Drug Discount Card Market Outlook, By Other Therapeutic Categories (2021-2030) ($MN)
  • Table 124 Middle East & Africa Drug Discount Card Market Outlook, By Sales Channel (2021-2030) ($MN)
  • Table 125 Middle East & Africa Drug Discount Card Market Outlook, By Online (2021-2030) ($MN)
  • Table 126 Middle East & Africa Drug Discount Card Market Outlook, By Offline (2021-2030) ($MN)
  • Table 127 Middle East & Africa Drug Discount Card Market Outlook, By End User (2021-2030) ($MN)
  • Table 128 Middle East & Africa Drug Discount Card Market Outlook, By Generic Drugs (2021-2030) ($MN)
  • Table 129 Middle East & Africa Drug Discount Card Market Outlook, By Branded Drugs (2021-2030) ($MN)
  • Table 130 Middle East & Africa Drug Discount Card Market Outlook, By Specialty Medications (2021-2030) ($MN)
  • Table 131 Middle East & Africa Drug Discount Card Market Outlook, By Other End Users (2021-2030) ($MN)